Healthcare provider profile · identity verified

Shellian Simone Davis, DO

Internal Medicine · KANNAPOLIS, NC · NPI 1265960983

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1035	286
Amlodipine Besylate	Amlodipine Besylate	964	272
Losartan Potassium	Losartan Potassium	683	185
Omeprazole	Omeprazole	679	176
Levothyroxine Sodium	Levothyroxine Sodium	578	129
Lisinopril	Lisinopril	431	113
Pravastatin Sodium	Pravastatin Sodium	431	113
Rosuvastatin Calcium	Rosuvastatin Calcium	396	111
Potassium Chloride	Potassium Chloride	375	96
Gabapentin	Gabapentin	326	89
Furosemide	Furosemide	303	89
Fluticasone Propionate	Fluticasone Propionate	295	107
Metoprolol Succinate	Metoprolol Succinate	294	81
Metformin Hcl Er	Metformin Hcl	292	87
Montelukast Sodium	Montelukast Sodium	280	72
Albuterol Sulfate Hfa	Albuterol Sulfate	257	84
Pantoprazole Sodium	Pantoprazole Sodium	250	67
Metoprolol Tartrate	Metoprolol Tartrate	238	74
Hydralazine Hcl	Hydralazine Hcl	230	58
Trazodone Hcl	Trazodone Hcl	214	63
Simvastatin	Simvastatin	202	54
Tamsulosin Hcl	Tamsulosin Hcl	198	46
Sertraline Hcl	Sertraline Hcl	197	49
Buspirone Hcl	Buspirone Hcl	191	57
Allopurinol	Allopurinol	179	46
Eliquis	Apixaban	178	45
Famotidine	Famotidine	166	45
Meloxicam	Meloxicam	151	44
Spironolactone	Spironolactone	149	45
Warfarin Sodium	Warfarin Sodium	149	40
Hydrochlorothiazide	Hydrochlorothiazide	144	49
Metformin Hcl	Metformin Hcl	138	39
Atenolol	Atenolol	132	38
Ezetimibe	Ezetimibe	132	41
Escitalopram Oxalate	Escitalopram Oxalate	128	29
Ozempic	Semaglutide	127	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	126	35
Jardiance	Empagliflozin	114	28
Clopidogrel	Clopidogrel Bisulfate	113	32
Fluoxetine Hcl	Fluoxetine Hcl	111	30
Tizanidine Hcl	Tizanidine Hcl	104	40
Doxazosin Mesylate	Doxazosin Mesylate	103	24
Isosorbide Mononitrate Er	Isosorbide Mononitrate	99	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	94	28
Zolpidem Tartrate	Zolpidem Tartrate	94	11
Carvedilol	Carvedilol	92	27
Esomeprazole Magnesium	Esomeprazole Magnesium	92	22
Torsemide	Torsemide	92	22
Tramadol Hcl	Tramadol Hcl	85	16
Duloxetine Hcl	Duloxetine Hcl	83	17
Mounjaro	Tirzepatide	80	21
Mirtazapine	Mirtazapine	78	23
Irbesartan	Irbesartan	75	22
Fenofibrate	Fenofibrate	74	22
Alprazolam	Alprazolam	73	suppressed
Lovastatin	Lovastatin	73	16
Pioglitazone Hcl	Pioglitazone Hcl	73	21
Symbicort	Budesonide/Formoterol Fumarate	73	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	72	16
Venlafaxine Hcl Er	Venlafaxine Hcl	70	14
Finasteride	Finasteride	69	17
Trulicity	Dulaglutide	69	suppressed
Citalopram Hbr	Citalopram Hydrobromide	64	20
Donepezil Hcl	Donepezil Hcl	61	13
Benazepril Hcl	Benazepril Hcl	59	14
Nifedipine Er	Nifedipine	58	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	57	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	54	11
Bupropion Xl	Bupropion Hcl	51	14
Clonazepam	Clonazepam	51	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	47	15
Diclofenac Sodium	Diclofenac Sodium	47	26
Clonidine Hcl	Clonidine Hcl	45	suppressed
Telmisartan	Telmisartan	44	suppressed
Breo Ellipta	Fluticasone/Vilanterol	43	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	suppressed
Januvia	Sitagliptin Phosphate	39	suppressed
Prednisone	Prednisone	38	28
Verapamil Er	Verapamil Hcl	38	suppressed
Glipizide Er	Glipizide	37	11
Lorazepam	Lorazepam	37	suppressed
Propranolol Hcl	Propranolol Hcl	37	11
Xarelto	Rivaroxaban	37	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	34	suppressed
Pregabalin	Pregabalin	33	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Colestipol Hcl	Colestipol Hcl	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	11
Triamcinolone Acetonide	Triamcinolone Acetonide	31	12
Diltiazem 24hr Er	Diltiazem Hcl	30	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Estradiol	Estradiol	26	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	25	suppressed
Ramipril	Ramipril	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Colchicine	Colchicine	24	14
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Nystatin	Nystatin	24	21
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Synthroid	Levothyroxine Sodium	23	suppressed
Tresiba Flextouch U-200	Insulin Degludec	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Methocarbamol	Methocarbamol	22	suppressed
Livalo	Pitavastatin Calcium	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	20
Klor-Con M20	Potassium Chloride	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	19	suppressed
Fenofibrate	Fenofibrate,micronized	19	suppressed
Ondansetron Odt	Ondansetron	19	15
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	16	suppressed
Linzess	Linaclotide	16	suppressed
Nitroglycerin	Nitroglycerin	16	14
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Niacin Er	Niacin	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Baclofen	Baclofen	14	suppressed
Fosinopril Sodium	Fosinopril Sodium	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	14	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Verapamil Sr	Verapamil Hcl	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Azithromycin	Azithromycin	12	11
Glipizide	Glipizide	12	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	12	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Valsartan	Valsartan	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Synjardy	Empagliflozin/Metformin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error